DLA Piper | USA | 7 Sep 2021
On August 24, 2021, Senate Finance Committee members Ron Wyden (D-OR), Sherrod Brown (D-MA) and Mark R. Warner (D-VA) released a discussion draft…
Dechert LLP | USA | 23 Aug 2021
U.S. Senate Finance Committee Chair Ron Wyden (D-Ore.) and Senator Sheldon Whitehouse (D-R.I.) on August 5, 2021, introduced legislation entitled the…
Reed Smith LLP | USA | 19 Apr 2019
Recent Congressional hearings and markups have concentrated on prescription drug pricing, insurance access, and other health topics. For instance…
Baker & Hostetler LLP | USA | 8 Apr 2019
Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session…
McGuireWoods Consulting LLC | USA | 8 Apr 2019
Coming Week’s Highlights: Congress will continue to examine drug pricing; on Tuesday, the Senate Finance Committee will hold the third in a series of…
Morgan, Lewis & Bockius LLP | USA | 4 Apr 2019
In a March 19 letter to CMS and HHS-OIG, Senators Chuck Grassley (R-IA) and Ron Wyden (D-OR) continued their oversight efforts regarding…
Covington & Burling LLP | USA | 28 Mar 2019
On March 25, 2019, the U.S. Court of International Trade ("CIT") denied a constitutional challenge to Section 232 of the Trade Expansion Act of 1962…
Reed Smith LLP | USA | 25 Mar 2019
The Senate Finance Committee recently called for federal agencies to begin investigating physician owned distributors’ (PODs) alleged noncompliance…
Baker & Hostetler LLP | USA | 25 Mar 2019
Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session…
Potomac Law Group PLLC | OECD, USA | 21 Mar 2019
The US government reopened January 26th with a short-term deal reached to fund those government operations without approved fiscal year spending until…